CLASE 3 DetecciÃ³n de Anticuerpos - Hospital Privado

More documents

Recommendations

Info

Citometría <strong>de</strong> Flujo
Page 1: Anticuerpos y Trasplante“crossmat
Page 4 and 5: Sensibilización y trasplanteRecept
Page 6 and 7: Crossmatch• Objetivos:*Detectar A
Page 8 and 9: Métodos
Page 10 and 11: Reacción CDC
Page 12 and 13: CDC + Antiglobulina Humana> sensibi
Page 14: Crossmatch por ELISA
Page 19 and 20: SSC vs FSCComplejidadinternaGranulo
Page 21 and 22: Principio del cross-matchAntígenoS
Page 23 and 24: XM (+) y XM (-)B+ B-T+ T-
Page 25 and 26: Variantes
Page 27 and 28: Crossmatch vs Panel (PRA)% de react
Page 29 and 30: Crossmatch Contra Panel (CDC)Célul
Page 31 and 32: Crossmatch Contra Panel (CF)
Page 33 and 34: Crossmatch contra donante
Page 35 and 36: Crossmatch T y B contra donanteComp
Page 37 and 38: Autoanticuerpos• Pac.con LES• P
Page 39 and 40: Separación de poblaciones de linfo
Page 41 and 42: Resultados vs. RiesgoCitotoxicidad
Page 43 and 44: Paciente sensibilizadoFuentes de se
Page 45: Tecnología Luminex
Page 51 and 52: PMTPhoto Multiplier Tube/RepReporte
Page 53 and 54: Descripción>712nm575nm675nmExcitat
Page 56 and 57: LABMAS
Page 58 and 59: Principio BásicoAloanticuerpoPE an
Page 60 and 61: Detección por R-PhycoerythrinConju
Page 62: LSM - Class I and II Screening
Page 66 and 67:
The cell surface is a jungle!
Page 68 and 69:
XM Virtual
Page 70 and 71:
cPRA (calculated PRA)http://www.uno
Page 72 and 73:
Acs vs sobrevida del injerto•Ac d
Page 74 and 75:
Anticuerpos y clínica del txPo-Cha
Page 76 and 77:
Anti-MICANEJM 357 (13) 2007
Page 78:
Anticuerpos vs tiempo post-txPo-Cha
show all

CLASE 3 DetecciÃ³n de Anticuerpos - Hospital Privado

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?